tiprankstipranks
Trending News
More News >
K Pharma,Inc. (JP:4896)
:4896
Japanese Market

K Pharma,Inc. (4896) Financial Statements

Compare
0 Followers

K Pharma,Inc. Financial Overview

K Pharma,Inc.'s market cap is currently ¥8.01B. The company's EPS TTM is ¥-20.44; its P/E ratio is -8.86; K Pharma,Inc. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 0.00¥ 1.00B¥ 0.00¥ 0.00
Gross Profit¥ 0.00¥ 910.00M¥ 0.00¥ -6.80M
Operating Income¥ -836.35M¥ 366.06M¥ -353.77M¥ -219.49M
EBITDA¥ -844.10M¥ 366.06M¥ -390.53M¥ -222.31M
Net Income¥ -846.46M¥ 260.33M¥ -392.43M¥ -228.72M
Balance Sheet
Cash & Short-Term Investments¥ 2.27B¥ 3.27B¥ 1.34B¥ 188.78M
Total Assets¥ 2.35B¥ 3.31B¥ 1.37B¥ 205.77M
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -2.27B¥ -3.27B¥ -1.34B¥ -188.78M
Total Liabilities¥ 94.76M¥ 209.13M¥ 38.30M¥ 26.88M
Stockholders' Equity¥ 2.26B¥ 3.10B¥ 1.34B¥ 178.89M
Cash Flow
Free Cash Flow¥ -998.21M¥ 444.62M¥ -393.44M¥ -196.32M
Operating Cash Flow¥ -983.72M¥ 454.43M¥ -363.48M¥ -196.32M
Investing Cash Flow¥ -14.49M¥ -11.10M¥ -32.74M¥ -250.00K
Financing Cash Flow¥ 0.00¥ 1.49B¥ 1.54B¥ 368.20M
Currency in JPY

K Pharma,Inc. Earnings and Revenue History

K Pharma,Inc. Debt to Assets

K Pharma,Inc. Cash Flow

K Pharma,Inc. Forecast EPS vs Actual EPS